On September 21, Cassandra DiNova will be participating in the AHI Leadership Summit and presenting on the topic, “Compliance with Part 2 Regulations in Telemedicine.”

Program Description:

During the COVID-19 pandemic, substance abuse providers turned to telemedicine to provide needed services to their patients. However, substance abuse providers were still subject to federal confidentiality regulations,Read More

Brian Bank, Michelle Bholan and Geoffrey Kaiser secured pre-answer dismissal of various False Claims Act claims brought against three New York nephrologists by a relator, also a nephrologist.

The action, which the relator brought on behalf of the United States of America under the False Claims Act’s qui tam provisions, alleged two theories against the

Read More

On Friday, September 18 Marc Ullman is speaking at the SupplySide Education Series “Testing trials for contract lab partnerships” webinar.

The session will explore:

• How to choose the right lab and how often a lab should be audited
• How to ensure tests are fit for purpose and what standards should be used,
• COVID-19-related factors

Read More

Marc Ullman was featured in a NutraIngredients-USA podcast, “Are brands responsible for consumer reviews?”

Recently the National Advertising Decision (NAD) addressed when companies will be liable for consumer reviews. Marc discussed both when they will be responsible, if they should respond to the reviews and best practices overall.

Click here to listen to the podcast.

Read More

Marc Ullman was quoted in NutraIngredients-USA, “Sabinsa ups ante in amla debate, demands AFS disclose alleged added Vitamin C.”

The article discusses how the Indian ingredient supplier Sabinsa Corp. has dialed up the pressure in its crusade about the chemical profile of amla with a legal action against a fellow supplier Applied Food Sciences.

Click

Read More

Marc Ullman was quoted in a NutraIngredients-USA article, “AHPA event aims to guide CBD industry.”

The article discusses how products containing cannabidiol (CBD) represent a rapidly growing yet uncertain market segment, with those in the industry often finding themselves with more questions than answers.

Click here to read the full article.

Read More

The prestigious Best Lawyers in America® has designated 10 Rivkin Radler LLP attorneys Ones to Watch in the NYS Bar.

The following attorneys were recognized:

Hackensack, N.Y.

Gene Y. Kang – Commercial Litigation/Litigation-Intellectual Property

Uniondale, N.Y.

Ashley Osadon Algazi – Health Care Law

Michelle A. Bholan – Commercial Litigation/Litigation- Labor and Employment

Kaitlyn E. Flynn

Read More

The prestigious Best Lawyers in America has included Rivkin Radler LLP in its U.S. rankings for 2021. For the first time, four Rivkin attorneys, all based in the firm’s Long Island office, have been named Lawyer of the Year:

Attorney                                Practice Area

Barry I. Levy                           Litigation-Health Care

Brian S. Conneely                  Employment Law-Management

Wendy H.

Read More

Marc Ullman was quoted in a NutraIngredients USA article, “Upcoming event aims to help fill regulatory holes in hemp/CBD industry.”

The article discusses how CBD firms are often unprepared for the regulatory compliance side of operating a dietary supplement firm. The upcoming event that is being discussed in the article looks to assist with that.

Read More

On August 11, John Queenan will be a panelist at Albany Law’s Virtual-Recent Graduate CLE.

He will be speaking on the topic of “Starting Strong: Case Considerations/Initial To-Dos/Early Case Assessment and Action.”

Click here to register. A zoom link will be sent over email.

Read More